2025 annual financial data
Fate Therapeutics 2025 Operating margin
Fate Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -2,222.45%.
Operating income was -147,704,000 USD and net income was -136,315,000 USD.
Operating cash flow was -106,084,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,646,000 USD
- Operating income
- -147,704,000 USD
- Net income
- -136,315,000 USD
- Operating cash flow
- -106,084,000 USD